Sort
10,766 grants matching “checkpoint inhibitor”
Epithelial-Mesenchymal Interactions in Pulmonary Fibrosis and Chronic Allograft Dysfunction (CLAD)
$2,368,307Paul Wesley Noble · Cedars-Sinai Medical Center · P01 · FY2019 · HL
Epithelial-Mesenchymal Interactions in Pulmonary Fibrosis and Chronic Allograft Dysfunction (CLAD)
$2,368,307Paul Wesley Noble · Cedars-Sinai Medical Center · P01 · FY2022 · HL
Epithelial-Mesenchymal Interactions in Pulmonary Fibrosis and Chronic Allograft Dysfunction (CLAD)
$2,368,307Paul Wesley Noble · Cedars-Sinai Medical Center · P01 · FY2020 · HL
Genes and signals controlling mammalian hematopoiesis.
$2,368,007Paul E Love · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2022 · HD
Molecular Targeted Radionuclide Therapy for Tumor Immunomodulation and Enhancing Immunotherapy Response
$2,361,658Jamey P Weichert · University Of Wisconsin-Madison · P01 · FY2024 · CA
Leveraging Observational (Real World) Data to Advance Precision Oncology
$2,357,014Charles L Sawyers · Sloan-Kettering Inst Can Research · P01 · FY2025 · CA
Yale Head and Neck Cancer SPORE: Overcoming Treatment Resistance in Head and Neck Cancer
$2,354,716Barbara Burtness · Yale University · P50 · FY2020 · DE
SPORE in Skin Cancer
$2,351,294Meenhard Herlyn · Wistar Institute · P50 · FY2025 · CA
Center for Cancer Immunology and Immunotherapy (CCII)
$2,349,699Jun Yan · University Of Louisville · P20 · FY2025 · GM
Epigenetic Therapies - New Approaches
$2,345,381Jean-Pierre J Issa · Coriell Institute For Medical Research · P50 · FY2022 · CA
Epigenetic Therapies - New Approaches
$2,345,381Jean-Pierre J Issa · Coriell Institute For Medical Research · P50 · FY2023 · CA
Dana-Farber/Harvard Cancer Center SPORE in Breast Cancer
$2,345,277Kornelia Polyak · Dana-Farber Cancer Inst · P50 · FY2021 · CA
Spatiotemporal Tumor Analytics for Guiding Sequential Targeted-Inhibitor: Immunotherapy Combinations (ST-Analytics)
$2,342,452James R. Heath · Institute For Systems Biology · U54 · FY2024 · CA
Yale SPORE in Lung Cancer (YSILC): The Biology and Personalized Treatment of Lung Cancer
$2,341,652Roy S Herbst · Yale University · P50 · FY2025 · CA
Center for Cancer Immunology and Immunotherapy (CCII)
$2,337,631Jun Yan · University Of Louisville · P20 · FY2020 · GM
University of Texas Southwestern Medical Center SPORE in Kidney Cancer
$2,336,997James Brugarolas · Ut Southwestern Medical Center · P50 · FY2025 · CA
The Memorial Sloan Kettering Cancer Center SPORE in Pancreas Cancer
$2,336,129Eileen Mary O'Reilly · Sloan-Kettering Inst Can Research · P50 · FY2023 · CA
The University of Texas MD Anderson Cancer Center SPORE in Hepatocellular Carcinoma
$2,332,104Laura Beretta · University Of Tx Md Anderson Can Ctr · P50 · FY2020 · CA
The Memorial Sloan Kettering Cancer Center SPORE in Pancreas Cancer
$2,329,651Eileen Mary O'Reilly · Sloan-Kettering Inst Can Research · P50 · FY2022 · CA
Genetics and Biology of Pancreatic Ductal Adenocarcinoma
$2,327,780Ronald Anthony Depinho · University Of Tx Md Anderson Can Ctr · P01 · FY2022 · CA
SPORE in Gastrointestinal Cancers
$2,325,001Alison P Klein · Johns Hopkins University · P50 · FY2022 · CA
Lymphoma Specialized Program of Research Excellence (SPORE) in Human Cancer
$2,325,000George J Weiner · University Of Iowa · P50 · FY2019 · CA
Yale SPORE in Skin Cancer
$2,325,000Marcus W Bosenberg · Yale University · P50 · FY2021 · CA
SPORE in Gastrointestinal Cancers
$2,324,999Alison P Klein · Johns Hopkins University · P50 · FY2019 · CA
Yale SPORE in Skin Cancer
$2,324,892Marcus W Bosenberg · Yale University · P50 · FY2019 · CA